Skip to content
SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%
Market News

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Business - Latest - Google News · September 4, 2026

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal  WSJNovartis, Ionis’ experimental heart drug misses key goal in closely watched trial  ReutersThe Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists  The New York TimesRoyalty Pharma expects modest return despite pelacarsen trial failure  in.investing.comNovartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial  Fierce Biotech

View original source →

More News

Trade Setup for August 31: Top 15 things to know before the opening bell
DA hike July 2026: Will DA rise to 64% from 60%? ₹18,000, to ₹56,100 basic salary | Calculate your likely increase
2026 Maruti WagonR Facelift Spied – New 3 Cyl Engine, Underbody CNG Likely
The Secret Reason Apple Never Cuts iPhone Prices In India